Windtree Therapeutics Inc (WINT) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Windtree Therapeutics Inc  (WINT)


Windtree Therapeutics Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WINT Gross Profit Margin (Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1 		(Dec 31 2024)
Q4 		(Sep 30 2024)
Q3
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $-0.04
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-0.04
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2025 Gross Profit Margin
Learn about Gross Margin
WINT's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
51.23 % 36.06 % 23.82 %
(Sep 30 2014)   (Dec 31 2014)


WINT Gross Income Trends • More of WINT's Profitabilty Ratios • WINT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
WINT's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
WINT's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for WINT's Competitors
Gross Profit Margin Profit Margin for Windtree Therapeutics Inc's Suppliers
Gross Profit Margin Profit Margin for WINT's Customers

You may also want to know
WINT's Annual Growth Rates WINT's Profitability Ratios WINT's Asset Turnover Ratio WINT's Dividend Growth
WINT's Roe WINT's Valuation Ratios WINT's Financial Strength Ratios WINT's Gross Profit Growth
WINT's Roa WINT's Inventory Turnover Ratio WINT's Growth Rates WINT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2025, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2025 MRQ Gross ProfitSep 30 2025 MRQ Revenue
Immunocore Holdings Plc  99.51 %$ 103.180  Millions$ 103.693  Millions
Immunitybio inc   99.45 %$ 31.884  Millions$ 32.061  Millions
Biocryst Pharmaceuticals Inc   98.63 %$ 157.208  Millions$ 159.395  Millions
Neurocrine Biosciences Inc   98.24 %$ 780.900  Millions$ 794.900  Millions
Agenus Inc  97.88 %$ 29.593  Millions$ 30.235  Millions
Exelixis Inc   96.89 %$ 579.181  Millions$ 597.755  Millions
Humacyte Inc   94.54 %$ 4.502  Millions$ 4.762  Millions
Tarsus Pharmaceuticals Inc   93.00 %$ 110.388  Millions$ 118.697  Millions
BioStem Technologies, Inc.  88.50 %$ 9.269  Millions$ 10.473  Millions
Zeo Scientifix Inc   84.52 %$ 1.398  Millions$ 1.654  Millions
Halozyme Therapeutics Inc   84.41 %$ 299.022  Millions$ 354.264  Millions
Adaptive Biotechnologies Corporation  80.68 %$ 75.816  Millions$ 93.973  Millions
X4 Pharmaceuticals Inc  80.11 %$ 1.414  Millions$ 1.765  Millions
Gilead Sciences Inc   79.80 %$ 6,200.000  Millions$ 7,769.000  Millions
Moderna Inc   79.63 %$ 809.000  Millions$ 1,016.000  Millions
Ginkgo Bioworks Holdings Inc   78.95 %$ 30.660  Millions$ 38.837  Millions
Alpha Cognition Inc.  77.70 %$ 2.207  Millions$ 2.841  Millions
Vericel Corporation  73.46 %$ 49.585  Millions$ 67.503  Millions
Biogen Inc   73.39 %$ 1,860.300  Millions$ 2,534.700  Millions
Novavax inc   69.49 %$ 48.949  Millions$ 70.445  Millions
Pelthos Therapeutics Inc   68.73 %$ 5.090  Millions$ 7.406  Millions
Scilex Holding Company  68.48 %$ 7.231  Millions$ 10.560  Millions
Coherus Oncology inc   67.84 %$ 7.850  Millions$ 11.571  Millions
Amgen Inc   67.75 %$ 6,475.000  Millions$ 9,557.000  Millions
Xtant Medical Holdings Inc   66.66 %$ 21.992  Millions$ 32.992  Millions
Bio techne Corp  65.75 %$ 188.112  Millions$ 286.112  Millions
Elutia Inc   64.95 %$ 1.853  Millions$ 2.853  Millions
Galaxy Enterprises Inc   60.07 %$ 0.113  Millions$ 0.188  Millions
Adma Biologics Inc   56.60 %$ 75.626  Millions$ 133.626  Millions
Protalix Biotherapeutics inc   53.37 %$ 9.527  Millions$ 17.851  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.